article thumbnail

5 strategies for biotech startups to outlast a market downturn

TechCrunch

More posts by this contributor 3 tips for biotech startups seeking non-dilutive capital to weather the downturn Founders in the biotech industry are no strangers to challenges. Inflationary market dynamics and ongoing fiscal tightening continue to pose significant risks to capital commitments.

Biotech 231
article thumbnail

In an increasingly hot biotech market, protecting IP is key

TechCrunch

2021 should be a banner year for biotech startups that make smart choices early. After a record year for biotech investment in 2020 — during which the industry saw $28.5 billion invested across 1,073 deals — the market for new innovations remains strong. More posts by this contributor. Kevin O’Connor. Contributor.

Biotech 240
article thumbnail

Biotech proved a surprisingly bright spot in 2022’s startup correction

TechCrunch

No startup sector was entirely immune from 2022’s market uncertainty — except maybe AI — but some proved more resilient than others. Biotech was one of the most fortunate. Those figures fell short of the 1,415 biotech deals struck in 2021 worth a total of $39 billion. The sector recorded 1,054 U.S.-based

Biotech 237
article thumbnail

6 investors discuss why AI is more than just a buzzword in biotech

TechCrunch

That’s why we weren’t very surprised when a slew of investors told us they rarely see a biotech startup that doesn’t incorporate AI in some form or other these days. But despite becoming quite the buzzword, AI’s apparent ubiquity in biotech isn’t actually driving deal flow or higher valuations.

Biotech 242
article thumbnail

As AI pervades biotech, what are investors looking for in 2023?

TechCrunch

JP Morgan’s announcement comes at a time when, in the words of B Capital general partner and head of healthcare Robert Mittendorff M.D, “public market biotechs are dramatically down as interest rates rise and the focus on near-term development outweighs the promise of longer-term results and approvals.”

Biotech 246
article thumbnail

Biotech Boom: Executive Search Strategies in Life Sciences

N2Growth Blog

Additionally, the industry’s highly regulated nature means that executives must have a keen eye for compliance and a strong ability to navigate the ever-changing market dynamics. Top executive search firms also bring a unique set of resources and expertise to the table when it comes to attracting top talent for biotech companies.

Biotech 178
article thumbnail

The Week’s 10 Biggest Funding Rounds: Crusoe Energy, Insider And Biotech Raise Big

Crunchbase News

startups raised half a billion dollars apiece, and another eight raised $100 million or more, with industries from cybersecurity to biotech to AI represented. tied) Insider , $500M, digital marketing: Marketing tech platform Insider raised a $500 million Series E led by General Atlantic to fund its expansion in the U.S.

Biotech 106